FDA approves therapy to protect bone marrow cells from effects of chemotherapy

Brain activity can predict resilience against post-traumatic stress
19 February 2021
BioNTech/Pfizer say vaccine can stand warmer temperatures
19 February 2021

FDA approves therapy to protect bone marrow cells from effects of chemotherapy

The U.S. Food and Drug Administration approved the first therapy in its class to reduce the frequency of bone marrow suppression induced by chemotherapy for extensive-stage small cell lung cancer, the agency announced Friday.

Comments are closed.